Oct 10, 2022 7:00 am EDT Castle Biosciences to Present Data Supporting the Clinical Value of Its Suite of Skin Cancer Tests through Multiple Oral Presentations at the 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting
Sep 23, 2022 7:00 am EDT Castle Biosciences Announces Publication of Study Demonstrating the Integration of DecisionDx®-Melanoma and Clinicopathologic Factors Provides Optimized, Personalized Survival Prognoses for Patients with Cutaneous Melanoma
Sep 21, 2022 7:00 am EDT Castle Biosciences Presents Clinical Use Scenarios for Its Diagnostic Gene Expression Profile Tests at Maui Derm NP+PA Fall 2022 Conference
Sep 20, 2022 4:05 pm EDT Castle Biosciences Presents Foundational Guideposts and Three-Year Financial Targets at 2022 Investor Day
Sep 13, 2022 7:00 am EDT Castle Biosciences Honored with a 2022 AZBio Fast Lane Award from the Arizona Bioindustry Association
Aug 4, 2022 7:00 am EDT American Gastroenterological Association (AGA) Clinical Practice Update States That TissueCypher® May Be Beneficial for Risk-Stratification of Patients with Non-Dysplastic Barrett’s Esophagus
Aug 3, 2022 7:00 am EDT Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
